|Videos|April 27, 2023
Interview with Scorpius BioManufacturing’s Steven Lavezoli
Author(s)Scorpius BioManufacturing
Key Learning Objectives:
- Demonstrate that Scorpius has the expertise to bring large molecule drugs to the clinic
- Make the industry aware we have immediately available capacity
- Explain how Scorpius values the client-CDMO partnership
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Related Content
Trending on Pharmaceutical Technology
1
FDA Grants Priority Review For Pfizer’s Marstacimab for Hemophilia A or B
2
Drug Digest: Outsourcing Partnerships Fuel Global Biopharma Discovery and Scale-Up
3
PharmTech Weekly Roundup - February 6, 2026
4
Women in STEM: Early Phase Drug Development
5